A look to the past - what has had the biggest impact on lipids in the last four decades? A personal perspective

被引:19
作者
Banach, Maciej [1 ,2 ,3 ,4 ]
Surma, Stanislaw [5 ]
机构
[1] Med Univ Lodz, Dept Prevent Cardiol & Lipidol, 281-289 Rzgowska St, PL-93338 Lodz, Poland
[2] Johns Hopkins Univ, Ciccarone Ctr Prevent Cardiovasc Dis, Dept Med, Div Cardiol,Sch Med, Baltimore, MD USA
[3] Univ Zielona Gora, Cardiovasc Res Ctr, Zielona Gora, Poland
[4] Polish Mothers Mem Hosp, Dept Cardiol & Adult Congenital Heart Dis, Res Inst, Lodz, Poland
[5] Med Univ Silesia, Fac Med Sci Katowice, Katowice, Poland
关键词
LOWERING THERAPY; RISK; EFFICACY; SAFETY;
D O I
10.5114/aoms/166256
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:559 / 564
页数:6
相关论文
共 47 条
[1]   Triglyceride Levels and Residual Risk of Atherosclerotic Cardiovascular Disease Events and Death in Adults Receiving Statin Therapy for Primary or Secondary Prevention: Insights From the KP REACH Study [J].
Ambrosy, Andrew P. ;
Yang, Jingrong ;
Sung, Sue Hee ;
Allen, Amanda R. ;
Fitzpatrick, Jesse K. ;
Rana, Jamal S. ;
Wagner, Jeffrey ;
Philip, Sephy ;
Abrahamson, David ;
Granowitz, Craig ;
Go, Alan S. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (20)
[2]  
[Anonymous], 1994, LANCET, V344, P1383
[3]   Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force [J].
Averna, Maurizio ;
Banach, Maciej ;
Bruckert, Eric ;
Drexel, Heinz ;
Farnier, Michel ;
Gaita, Dan ;
Magni, Paolo ;
Maerz, Winfried ;
Masana, Luis ;
Mello e Silva, Alberto ;
Reiner, Zeljko ;
Ros, Emilio ;
Vrablik, Michal ;
Zambon, Alberto ;
Zamorano, Jose L. ;
Stock, Jane K. ;
Tokgozoglu, Lale S. ;
Catapano, Alberico L. .
ATHEROSCLEROSIS, 2021, 325 :99-109
[4]  
Banach M, 2022, EUR HEART J OPEN, V2, po
[5]   Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP) [J].
Banach, Maciej ;
Penson, Peter E. ;
Farnier, Michel ;
Fras, Zlatko ;
Latkovskis, Gustavs ;
Laufs, Ulrich ;
Paneni, Francesco ;
Parini, Paolo ;
Pirro, Matteo ;
Reiner, Zeljko ;
Vrablik, Michal ;
Escobar, Carlos .
PROGRESS IN CARDIOVASCULAR DISEASES, 2023, 79 :2-11
[6]   2022: the year in cardiovascular disease - the year of upfront lipid lowering combination therapy [J].
Banach, Maciej ;
Reiner, Zeljko ;
Cicero, Arrigo F. G. ;
Sabouret, Pierre ;
Viigimaa, Margus ;
Sahebkar, Amirhossein ;
Postadzhiyan, Arman ;
Gaita, Dan ;
Pella, Daniel ;
Penson, Peter E. .
ARCHIVES OF MEDICAL SCIENCE, 2022, 18 (06) :1429-1434
[7]   Personalized management of dyslipidemias in patients with diabetes-it is time for a new approach (2022) [J].
Banach, Maciej ;
Surma, Stanislaw ;
Reiner, Zeljko ;
Katsiki, Niki ;
Penson, Peter E. ;
Fras, Zlatko ;
Sahebkar, Amirhossein ;
Paneni, Francesco ;
Rizzo, Manfredi ;
Kastelein, John .
CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
[8]   Individualized therapy in statin intolerance: the key to success [J].
Banach, Maciej ;
Cannon, Christopher P. ;
Paneni, Francesco ;
Penson, Peter E. .
EUROPEAN HEART JOURNAL, 2023, 44 (07) :544-546
[9]   Statin intolerance: time to stop letting it get in the way of treating patients [J].
Banach, Maciej .
LANCET, 2022, 400 (10355) :791-793
[10]   Treatment adherence and effect of concurrent statin intensity on the efficacy and safety of alirocumab in a real-life setting: results from ODYSSEY APPRISE [J].
Banach, Maciej ;
Lopez-Sendon, Jose Luis ;
Averna, Maurizio ;
Cariou, Bertrand ;
Loy, Megan ;
Manvelian, Garen ;
Batsu, Isabela ;
Poulouin, Yann ;
Gaudet, Daniel .
ARCHIVES OF MEDICAL SCIENCE, 2022, 18 (02) :285-292